Cargando…
Crossing the Rubicon: A fine line between waiting and vaccinating adolescents against COVID-19
Several countries with advanced adult COVID-19 immunisation programmes have already started vaccinating adolescents with an mRNA vaccine that recently received emergency use authorisation for 12–15 year-olds. The decision to vaccinate adolescents remains highly divisive among parents, clinicians, po...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd on behalf of The British Infection Association.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294773/ https://www.ncbi.nlm.nih.gov/pubmed/34302866 http://dx.doi.org/10.1016/j.jinf.2021.07.015 |